Huaitian Liu

National Institutes of Health — United States

Medicine · Health Sciences

18h-index1.7kcitations100works1.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(19), Cancer Genomics and Diagnostics(17), Genetic factors in colorectal cancer(14), Pancreatic and Hepatic Oncology Research(8), Cancer Cells and Metastasis(8)

Publications100 total

Cytoprotective role of octacosanol in lipopolysaccharide-induced inflammation
Frontiers in Immunology·2026Open Access
Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortality
2026Open Access
NAT10 promotes cancer metastasis by modulating p300/CBP activity through chromatin-associated tRNA
Molecular Cell·2025Open Access
Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications
Pharmacology & Therapeutics·2025· 2 citedOpen Access
A Partition Function Algorithm to Evaluate Inferred Subclonal Structures in Single-Cell Sequencing Data
Lecture notes in computer science·2025· 1 cited
Abstract 4147066: Octacosanol Reduces Lipopolysaccharide Induced Loss of Cellular Integrity of Primary Human Aorta Endothelial Cells
Circulation·2024· 1 cited
<scp>ELAPOR1</scp> induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
International Journal of Cancer·2024· 7 citedOpen Access
Abstract LB240: Cell type annotation using singleR with custom reference for single-nucleus multiome data derived from frozen human breast tumors
Cancer Research·2024
Abstract 6108: Investigation of breast tumor biology and microenvironment in women of African descent using a single cell multiomic approach
Cancer Research·2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer
2024Open Access
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
Carcinogenesis·2024· 6 citedOpen Access
Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progression
2024· 3 citedOpen Access
Establishment and Characterization of Amitrole-Induced Mouse Thyroid Adenomatous Nodule-Derived Cell Lines
Thyroid·2023Open Access
SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer
Cell Reports·2023· 32 citedOpen Access
Abstract 15340: Octacosanol Exerts Anti-Inflammatory Effects on Primary Human Aorta Endothelial Cells (HAEC) Induced With Lipopolysaccharides (LPS)
Circulation·2023· 2 cited
LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
2023Open Access
Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency
JCI Insight·2023· 11 citedOpen Access
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
2023· 2 citedOpen Access
Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response
Pharmacology & Therapeutics·2023· 28 citedOpen Access
Abstract LB174: Diabetes-associated breast cancer is molecularly distinct and shows DNA repair deficiency
Cancer Research·2023
page 1 of 5Next →

Frequent Co-authors

Maxwell P. Lee(17), Howard H. Yang(12), Yuuki Ohara(9), Joanna H. Shih(8), Tiffany H. Dorsey(7), Paloma Moreno(7), Stefan Ambs(7), S. Perwez Hussain(7), Lalage M. Wakefield(6), Helen Cawley(6), Azadeh Azizian(6), Jochen Gaedcke(6), Nader Hanna(6), Kent W. Hunter(5), James L. Mulshine(5), Alan D. Friedman(5), Shouhui Yang(5), Michael Ghadimi(5), Yu-an Yang(4), Hua Su(4)